Printer Friendly

Lupus; Key Q&A.

What causes lupus?

The immune system of a person with lupus is unbalanced, and this leads to excess targeting of normal tissue, causing inflammation, fever, achy joints, rashes and other problems. Virtually all lupus patients have autoantibodies in their blood at concentrations that can be detected by lab tests.

What are my risks for having lupus?

There is no way to predict who will get lupus and who won't. Women of childbearing age comprise the vast majority of cases, and the disease occurs more frequently in African-Americans, American Indians and Asians than in Caucasians. Risk to develop lupus is inherited, but only through a complicated series of interacting genes that may not be the same in all patients. People at high risk for lupus are more likely to develop it after exposure to an environmental trigger, which again, may not be identical in all patients. It is likely that some people with high risk genes for lupus will never develop the disease due to the lack of an environmental trigger.

Is there anything I can do to prevent lupus?

No. The disease is treatable and flares are controllable, but no one has discovered means of limiting your chances of developing the disease.

What are the most common symptoms of lupus?

The more common symptoms of lupus include joint pain, arthritis, unexplained fever, extended or severe fatigue, skin rashes, anemia and kidney damage. Other symptoms include neuropsychiatric problems, such as seizures, blood clotting problems, light sensitivity, hair loss, Raynaud's syndrome (fingers turning white or blue in the cold) and mouth or nose ulcers.

Is lupus curable?

Lupus is not curable, but it is treatable. Your health care professional can prescribe medications to alleviate symptoms, such as pain and inflammation. You can take action as well, by eating right, exercising, avoiding sunlight and getting plenty of rest.

Is it safe to have a baby even though I have lupus?

About 20 percent of lupus pregnancies have risk of miscarriage or stillbirth and about 25 percent are premature births. Preeclampsia is a potentially life-threatening condition that seems to occur more frequently in lupus patients. The risk for these outcomes increases if you have antiphospholipid antibodies. The good news is that appropriate treatments and specialized care from a high-risk OB team can markedly increase the odds for a successful and safe pregnancy. One to three percent of babies born to mothers with lupus are born with neonatal lupus, a condition that often resolves itself within three to six months. If you have certain autoantibodies (SSA-Ro and/or SSB La), you may need a fetal echocardiogram during your pregnancy. In most cases, this will lead to reassurance that the baby is fine. If you have a history of a stroke or current, active lupus kidney disease, it is not advisable to become pregnant.

What drugs are available to treat lupus?

Drugs prescribed for lupus include nonsteroidal anti-inflammatory agents, such as aspirin or ibuprofen; acetaminophen; antimalarials such as hydroxychloroquine (Plaquenil) and chloroquine (Aralen), corticosteroids such as prednisone or medrol; immune suppressants such as azathioprine (Imuran), methotrexate (Rheumatrex). mycophenolate mofetil (Cellcept) and leflunamide (Arava),; and cytotoxic drugs such as cyclophosphamide (Cytoxan).

How can flares be prevented or the symptoms lessened?

A lupus flare can occur for no discernible reason, although some patients believe that they have experienced triggers for the flares, such as sunlight, stress, overwork, infection, injuries, surgery and immunizations.


The Lupus Foundation of America. 2008. Accessed June 2008.

"Lupus Causes." The Mayo Clinic. October 2007. Accessed February 2008.

"Medicines." The Lupus Foundation of America. 2008. Accessed February 2008.

"COX-2 Selective and Non-Selective Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)." U.S. Food and Drug Administration Center for Drug Evaluation and Research. Updated April 15, 2005. Accessed June 3, 2005.

"FDA Issues Public Health Advisory on Vioxx as its Manufacturer Voluntarily Withdraws Its Product." U.S. Food and Drug Administration. Accessed October 1, 2004.

Lupus Foundation of America. Accessed June 8, 2004. Accessed June 8, 2004. Accessed June 8, 2004.

"Lupus: A Patient Care Guide for Nurses and Other Health Care Professionals." erythematosus." National Institute of Arthritis and Musculoskeletal and Skin Diseases. May 2001. Accessed June 8, 2004.

"Handout on Health: Systemic Lupus Erythematosus." National Institute of Arthritis and Musculoskeletal and Skin Diseases. Revised August 2003 Accessed June 8, 2004.

"Patient Information Sheet #1: Living With Lupus." National Institute of Arthritis and Musculoskeletal and Skin Diseases. May 2001. Accessed June 8, 2004.

"Treatment." Lupus Foundation of America. Accessed June 8, 2004

"Lupus is a Significant Health Issue for Women and People of Color." May 2001. The National Women's Health Information Center. Accessed June 8, 2004.

"Drugs Approved by the FDA: Drug Name: Mobicr (meloxicam) Tablets" CenterWatch Clinical Trials Listing Service. Updated Nov. 14 2000. Acessed June 8, 2004.

"Targets for New SLE Treatments" Division of Rheumatology of The Hospital for Special Surgery. January 2002. Accessed June 8, 2004.

Keywords: lupus, systemic lupus erythematosus, sle, lupus patients, women, flares, symptoms, medications, pregnancy, corticosteroids
COPYRIGHT 2008 National Women's Health Resource Center
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2008 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:NWHRC Health Center - Lupus
Article Type:Disease/Disorder overview
Geographic Code:1USA
Date:Jun 19, 2008
Previous Article:Lupus; Questions to Ask.
Next Article:Lupus; Lifestyle Tips.

Related Articles
Genelabs Completes Phase III Clinical Trial of GL701 for Lupus
Intestinal pseudo-obstruction as a presenting manifestation of systemic lupus erythematosus: case report and review of the literature.
Lupus; Diagnosis.
New Website Broadcasts Urgent Need for Lupus Clinical Trials.
MedImmune Advances Potential Treatment for Patients With Lupus.
Human Genome Sciences Reports Positive Data from Long-Term Treatment with LymphoStat-B(R) in Patients with Active Systemic Lupus Erythematosus.
Merck Serono Announces Initiation of Phase II/III Clinical Trial of Atacicept in Lupus Nephritis.
Corgenix Announces FDA Clearance for IgG Anti-AtherOx(R) Test Kit.
Medarex Announces Initiation of Phase 2 Clinical Development Program for the Treatment of Lupus.
Neuropsychiatric lupus: clinical and imaging aspects.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters